FDA Grants Fast Track Designation to PT217 for Extensive Stage Small Cell Lung Cancer
The FDA has granted fast track designation to PT217 for patients with extensive stage small cell lung cancer with disease progression.
Source: onclive.com
Pt217 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pt217 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pt217 Today - Breaking & Trending Today